Pulmonary Arterial Hypertension Stocks List

Recent Signals

Date Stock Signal Type
2021-05-14 ARNA New Downtrend Bearish
2021-05-14 ARNA Lower Bollinger Band Walk Weakness
2021-05-14 ARNA Slingshot Bearish Bearish Swing Setup
2021-05-14 ASND Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-05-14 EIGR NR7-2 Range Contraction
2021-05-14 EIGR NR7 Range Contraction
2021-05-14 EIGR Narrow Range Bar Range Contraction
2021-05-14 GILD Cup with Handle Other
2021-05-14 GILD NR7 Range Contraction
2021-05-14 GILD Upper Bollinger Band Walk Strength
2021-05-14 LQDA 50 DMA Support Bullish
2021-05-14 LQDA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-14 LQDA 20 DMA Resistance Bearish
2021-05-14 PFE NR7 Range Contraction
2021-05-14 PFE Cup with Handle Other
2021-05-14 PHAS 20 DMA Resistance Bearish
2021-05-14 PSTI Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-14 PSTI Lower Bollinger Band Walk Weakness
2021-05-14 RETA NR7 Range Contraction
2021-05-14 RETA New 52 Week Low Weakness
2021-05-14 RETA Doji - Bullish? Reversal
2021-05-14 RVPH Bullish Engulfing Bullish
2021-05-14 RVPH Narrow Range Bar Range Contraction

Recent News for Pulmonary Arterial Hypertension Stocks

Date Stock Title
May 14 PFE Brazil judge rules ex-health minister can remain silent in COVID inquiry
May 14 PFE 'Halftime Report' Traders Weigh In On JD, Alibaba And More
May 14 PFE Doctor: 'I will be wearing masks indoors for the foreseeable future’
May 14 PFE COVID SCIENCE-Delayed 2nd Pfizer/BioNTech shot boosts antibodies in elderly; COVID-19 obesity risk higher for men
May 14 LQDA Liquidia (LQDA) Investor Presentation - Slideshow
May 14 PFE New CDC study confirms mRNA vaccines can cut risk of symptomatic COVID-19 by 94%
May 14 PFE People choosing to ditch their masks will be a ‘gradual process’: Doctor
May 14 GILD People choosing to ditch their masks will be a ‘gradual process’: Doctor
May 14 LLY Why AbCellera Stock Crumbled Despite In-Line Royalties For Covid Drug
May 14 PFE Pfizer says 'good reason' to believe in success of anti-viral drug
May 14 PFE Delaying second Pfizer COVID-19 shot boots antibodies more than three-fold in elderly, U.K. study finds
May 14 PFE U.S. Will Send No New J&J Vaccines Doses to States Next Week
May 14 PFE Corcept's (CORT) Lead Drug Korlym Aids Growth Amid Competition
May 14 KROS Keros Therapeutics presents KER-012 preclinical data in pulmonary arterial hypertension in rodents
May 14 KROS Keros Therapeutics Presents Results from Preclinical Study of KER-012 in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference
May 14 PFE Delaying second Pfizer COVID shot boosts immune response in over-80s, study finds
May 14 PFE Why Pfizer Stock Didn't Soar After Its Fantastic Q1 Results
May 14 PFE 3 Things About Moderna That The Smartest Investors Know
May 14 PFE Chart Advisor: Safety First
May 14 PFE UPDATE 1-Vietnam seeks 31 mln doses of Pfizer-BioNTech vaccine in 2021

Pulmonary hypertension (PH or PHTN) is a condition of increased blood pressure within the arteries of the lungs. Symptoms include shortness of breath, syncope, tiredness, chest pain, swelling of the legs, and a fast heartbeat. The condition may make it difficult to exercise. Onset is typically gradual.The cause is often unknown. Risk factors include a family history, prior blood clots in the lungs, HIV/AIDS, sickle cell disease, cocaine use, COPD, sleep apnea, living at high altitudes, and problems with the mitral valve. The underlying mechanism typically involves inflammation of the arteries in the lungs. Diagnosis involves first ruling out other potential causes.There is no cure. Treatment depends on the type of disease. A number of supportive measures such as oxygen therapy, diuretics, and medications to inhibit clotting may be used. Medications specifically for the condition include epoprostenol, treprostinil, iloprost, bosentan, ambrisentan, macitentan, and sildenafil. A lung transplant may be an option in certain cases.While the exact frequency of the condition is unknown, it is estimated that about 1,000 new cases occur a year in the United States. Females are more often affected than males. Onset is typically between 20 and 60 years of age. It was first identified by Ernst von Romberg in 1891.

More about Pulmonary Arterial Hypertension
Browse All Tags